The recent classification of renal tumors is based on genetic evidence as well as on histologic features.
Malignant tumor includes clear cell renal carcinoma (RCC), multilocular cystic RCC, papillary RCC, chromophobe RCC, carcinoma of the collecting duct of Bellini, renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and mucinous tubular and spindle cell carcinoma. Benign tumor is subdivided into papillary adenoma, renal oncocytoma and metanephric adenoma. Recently, new disease entities such as acquired cystic disease-associated RCC, clear cell papillary RCC and renal carcinoma with t(6;11)(p21:q12) have been discovered. In this article, we briefly review and introduce the clinical, morphological and genetic features of these tumor entities.
Written by:
Kuroda N, Tanaka A. Are you the author?
Department of Pathology, Kochi Red Cross Hospital, 2-13-51 Shin-honmachi, Kochi City, Kochi, 780-8561, Japan.
Reference: Med Mol Morphol. 2013 Mar 26. Epub ahead of print.
doi: 10.1007/s00795-013-0033-0
PubMed Abstract
PMID: 23529139
UroToday.com Investigative Urology Section
